Menu
Back to Journals » Drug Design, Development and Therapy » Volume 7
An early indicator of drug success: Top Journal Selectivity Index
Authors Kissin I
Received 24 August 2012
Accepted for publication 6 November 2012
Published 13 February 2013 Volume 2013:7 Pages 93—98
DOI https://doi.org/10.2147/DDDT.S37324
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Igor Kissin
Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
Abstract: The Top Journal Selectivity Index (TJSI) is a scientometric index reflecting the potential importance of a new drug. It represents the ratio of the number of all types of articles on a particular drug in the top 20 journals relative to the number of articles in all (>5,000) biomedical journals covered by Medline over the 5 years since the drug’s introduction. The TJSI can be an indicator of a drug’s potential for sustained use: a higher score increases the probability of continuing success.
Keywords: bibliometrics, ‘me-too’ drugs, pharmaceutical market, scientometrics
© 2013 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.